Table 1.
Summary of the immunostaining of Fn14 across 462 samples from 169 patients with melanoma.
| Specimen | IHC score |
≥ 2+ | Percent | ||||
|---|---|---|---|---|---|---|---|
| 0 | 1+ | 2+ | 3+ | ||||
| Nevus | Thin | 4 | 1 | 9 | 21 | 30/35 | 84% |
| Thick | 7 | 7 | 38 | 35 | 73/87 | ||
| Primary | Thin | 4 | 1 | 24 | 42 | 66/71 | 92% |
| Thick | 9 | 3 | 50 | 57 | 107/119 | ||
| Metastases | Lymph node | 25 | 0 | 3 | 32 | 35/60 | 58% |
| Visceral | 38 | 1 | 7 | 44 | 51/90 | ||
Notes: IHC score is based on the percentage of epithelial cells stained in the tumor portion of the sample: “0,” less than 5% positive cells; “1,” 5–25% positive cells; “2,” >25– 75% positive cells; “3,” greater than 75% positive cells. Thin refers to lesions <1 mm; Thick refers to lesions > 1mm.